首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1756487

院內感染控制市場（按類型、最終用途、國家和地區）—2024 年至 2032 年行業分析、市場規模、市場佔有率及預測

Hospital Acquired Infection Control Market, By Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2025年05月15日 | 出版商:

AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年院內感染控制市場規模價值為 213.4598 億美元，2024 年至 2032 年的複合年成長率為 6.80%。

院內感染控制市場-市場動態

提高對院內感染（HAI）的認知

人們對醫院內感染風險和後果的認知不斷提高，是推動醫院內感染控制市場發展的重要因素。醫療專業人員、管理人員和患者越來越了解醫院內感染的危害，例如延長住院時間、增加醫療費用以及提高死亡率。這種日益增強的認知促使醫療機構優先考慮感染控制措施，並投資於先進的預防技術。包括世界衛生組織和美國疾病管制與預防中心在內的全球監管機構和衛生組織都發布了嚴格的指導方針，進一步強調了醫院內感染監測和控制的重要性。為此，醫院正採用強而有力的感染預防方案，包括使用抗菌表面、消毒設備和數位追蹤系統。此外，公共衛生運動和媒體報道也對一般民眾進行了教育，從而提高了病人對安全的期望。因此，已開發市場和新興市場對感染控制解決方案的需求都在不斷成長。

院內感染控制市場-關鍵見解

根據我們的研究分析師，全球院內感染控制市場預計在 2024 年至 2032 年期間的複合年成長率約為 6.80%。

2023 年按類型細分，設備類別佔據了市場主導地位。

根據最終用途細分，醫院和重症監護病房 (ICU) 在 2023 年創造了最多的收入。

按地區分類，2023年北美是收入最高的地區。

院內感染控制市場-細分分析：

全球院內感染控制市場分為三類：類型、最終用途和地區。

院內感染 (HAI) 控制市場按類型細分為設備、服務和耗材。設備包括滅菌設備、消毒系統和空氣淨化裝置，這些裝置對於維持無菌醫療環境至關重要。服務涵蓋由專業供應商提供的感染監測、培訓和合規性管理。消毒劑、防腐劑、手套、防護服和口罩等耗材是日常使用的，用於防止感染傳播。隨著對先進消毒技術（例如 UV-C 系統、自動滅菌器和 HEPA 過濾）的投資不斷增加，設備將佔據市場主導地位。醫院和醫療機構優先考慮耐用的基礎設施，以確保持續的感染預防，尤其是在重症監護室 (ICU) 和手術室等高風險區域。對長期感染控制解決方案和符合國際安全標準的追求正在加速尖端設備的採用。隨著醫療保健系統的現代化，設備預計將因其在綜合感染控制策略中的關鍵作用而佔據市場佔有率的領先地位。

院內感染 (HAI) 控制市場按最終用途分為醫院和重症監護病房 (ICU)、門診手術和診斷中心以及其他，包括長期護理機構和診所。由於醫院和 ICU 入院人數眾多、醫療程序複雜且感染傳播風險較高，預計它們將佔據市場主導地位。 ICU 尤其需要處理免疫功能低下的患者、侵入性設備以及長期住院，使其成為院內感染 (HAI) 的熱點。因此，這些病房需要嚴格的感染控制規程，並持續投資於設備、耗材和專業服務。全院衛生標準、政府法規和認證要求的實施進一步推動了該領域的需求。此外，全球 HAI 負擔的不斷加重以及降低相關醫療保健成本的需求，使得醫院和 ICU 成為感染控制解決方案的主要消費者。

院內感染控制市場-地理洞察

從地理分佈來看，院內感染控制市場分佈於北美、亞太、拉丁美洲、歐洲、中東和非洲。這些區域進一步根據業務來源國分類。

北美是院內感染 (HAI) 控制市場的主導地區，這得益於先進的醫療基礎設施、嚴格的政府法規以及日益增強的感染控制意識。美國擁有龐大的醫療體系，且醫院相關感染的盛行率不斷上升，在北美佔據最大的市場佔有率。美國疾病管制與預防中心 (CDC) 和其他監管機構實施嚴格的感染控制措施，鼓勵醫院和醫療保健提供者在設備、耗材和服務方面投入大量資金。此外，自動滅菌系統和空氣淨化裝置等先進技術的廣泛採用也進一步促進了市場成長。加拿大也發揮著重要作用，致力於透過公共衛生運動和醫療保健現代化來加強感染預防。

歐洲是醫院感染控制市場的另一個主導地區，得益於其強大的醫療保健體系和對病人安全的重視。歐盟已推出旨在改善感染預防和降低醫院內感染發生率的法規，從而促進了市場成長。德國、英國和法國等國家擁有完善的醫療保健基礎設施，並且擴大採用先進的感染控制技術，例如紫外線殺菌和抗菌表面塗層。該地區著重維持高醫療保健標準，加之人們對有效感染控制解決方案的認知和需求不斷成長，使得歐洲成為市場的關鍵參與者。此外，歐洲市場受益於醫療保健提供者和感染控制解決方案供應商之間的緊密合作，確保最佳實踐已廣泛採用。

院內感染控制市場-競爭格局：

院內感染 (HAI) 控制市場的競爭態勢由眾多老牌企業和專注於先進技術的新進者共同塑造。 3M、Belimed Inc.、Getinge 和 STERIS 等大型公司憑藉全面的感染控制解決方案（包括滅菌系統、消毒劑和個人防護裝備 (PPE)）佔據市場主導地位。這些公司以注重產品品質、合規性以及為增強產品功能而投入的大量研發力量而聞名。他們還在數位健康解決方案方面投入巨資，以改善感染監測和追蹤。此外，W&H 和 Midmark Corporation 等新進業者和創新者正在引入先進的滅菌設備和自動化系統，以提高安全性和效率。例如，市場中的關鍵參與者 Sterigenics 專注於伽馬射線滅菌技術，並在全球擴展其滅菌能力。這種競爭環境促進了創新，並推動了感染控制方案的改進，使醫療保健提供者和患者受益。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美院內感染控制關鍵製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模和預測（按類型）
- 北美市場規模及預測（依最終用途）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲院內感染控制主要製造商
- 歐洲市場規模及預測（按國家/地區）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模及預測（依最終用途）
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區醫院感染控制關鍵製造商
- 亞太市場規模及預測（按國家/地區）
- 亞太市場規模及預測（按類型）
- 亞太市場規模及預測（依最終用途）
- 印度
- 中國
- 韓國
- 日本
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲院內感染控制關鍵製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模與預測（按類型）
- 拉丁美洲市場規模及預測（依最終用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲醫院感染控制關鍵製造商
- 中東和非洲市場規模及預測（按國家/地區）
- 中東和非洲市場規模和預測（按類型）
- 中東和非洲市場規模及預測（按最終用途）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其餘地區

第 10 章：關鍵供應商分析-院內感染控制產業

競爭儀錶板
公司簡介
- 3M
- Belimed Inc.
- O&M Halyards
- Getinge
- ASP (Advanced Sterilization Products Services, Inc.)
- Sterigenics US, LLC - A Sotera Health Company
- MMM Group
- Midmark Corporation
- STERIS
- W&H
- Others

第 11 章：360 度分析師視角

第 12 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV5295

REPORT HIGHLIGHT

Hospital Acquired Infection Control Market size was valued at USD 21,345.98 Million in 2024, expanding at a CAGR of 6.80% from 2024 to 2032.

Hospital Acquired Infection (HAI) Control refers to the comprehensive strategies and practices implemented within healthcare facilities to prevent, monitor, and manage infections that patients acquire during their stay in a hospital or clinical setting. These infections typically develop 48 hours or more after admission and are not present or incubating at the time of entry. Effective HAI control involves a combination of strict hygiene protocols, sterilization of medical instruments, appropriate use of personal protective equipment (PPE), antimicrobial stewardship, and staff training. Surveillance systems are also essential to detect outbreaks and track infection trends. Key infections targeted include bloodstream infections, urinary tract infections, pneumonia, and surgical site infections. The aim is to protect both patients and healthcare workers, minimize complications, reduce healthcare costs, and improve patient outcomes. Continuous education, adherence to guidelines such as those from the CDC or WHO, and institutional commitment are critical to ensuring successful infection control in hospitals.

Hospital Acquired Infection Control Market- Market Dynamics

Rising Awareness of Hospital-Acquired Infections (HAIs)

Increasing awareness about the risks and consequences of hospital-acquired infections is a significant driver of the HAI control market. Healthcare professionals, administrators, and patients are becoming more informed about the dangers posed by HAIs, such as prolonged hospital stays, increased healthcare costs, and higher mortality rates. This growing awareness has prompted healthcare facilities to prioritize infection control measures and invest in advanced prevention technologies. Regulatory bodies and health organizations worldwide, including the WHO and CDC, have issued stringent guidelines, further emphasizing the importance of HAI surveillance and control. In response, hospitals are adopting robust infection prevention protocols, including the use of antimicrobial surfaces, sterilization equipment, and digital tracking systems. Additionally, public health campaigns and media coverage have educated the general population, leading to greater patient expectations for safety. As a result, the demand for infection control solutions is expanding across both developed and emerging markets.

HOSPITAL ACQUIRED INFECTION CONTROL Market- Key Insights

According to our research analyst, the global Hospital Acquired Infection Control Market is expected to develop at a CAGR of approximately 6.80% between 2024-2032.

Segmented by Type in 2023, the Equipment category dominated the market.

Based on End Use segmentation, the Hospitals and Intensive Care Units (ICUs) generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Hospital Acquired Infection Control Market- Segmentation Analysis:

The global Hospital Acquired Infection Control market is divided into three categories: type, end use and region.

The Hospital Acquired Infection (HAI) Control market is segmented by type into Equipment, Services, and Consumables. Equipment includes sterilization devices, disinfection systems, and air purification units essential for maintaining a sterile healthcare environment. Services encompass infection surveillance, training, and compliance management offered by specialized providers. Consumables such as disinfectants, antiseptics, gloves, gowns, and masks are used daily to prevent the spread of infections. Equipment is set to dominate the market, driven by increasing investments in advanced disinfection technologies such as UV-C systems, automated sterilizers, and HEPA filtration. Hospitals and healthcare facilities are prioritizing durable infrastructure that ensures consistent infection prevention, especially in high-risk areas like ICUs and operating rooms. The push for long-term infection control solutions and compliance with international safety standards is accelerating the adoption of cutting-edge equipment. As healthcare systems modernize, equipment is expected to lead in market share due to its critical role in comprehensive infection control strategies.

The Hospital Acquired Infection (HAI) Control market is categorized by end-use into Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, and Others, which include long-term care facilities and clinics. Hospitals and ICUs are projected to dominate the market due to the high volume of patient admissions, complex medical procedures, and increased risk of infection transmission in these settings. ICUs, in particular, deal with immunocompromised patients, invasive devices, and extended hospital stays, making them hotspots for HAIs. As a result, these units require strict infection control protocols and continuous investment in equipment, consumables, and specialized services. The implementation of hospital-wide hygiene standards, government regulations, and accreditation requirements further drives demand in this segment. Moreover, the rising global burden of HAIs and the need to reduce associated healthcare costs make hospitals and ICUs the leading consumers of infection control solutions.

Hospital Acquired Infection Control Market- Geographical Insights

Geographically, the Hospital Acquired Infection Control Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Hospital Acquired Infection (HAI) Control market, driven by advanced healthcare infrastructure, stringent government regulations, and increasing awareness about infection control. The United States, with its large healthcare system and rising prevalence of healthcare-associated infections, holds the largest market share in the region. The Centers for Disease Control and Prevention (CDC) and other regulatory bodies enforce strict infection control measures, encouraging hospitals and healthcare providers to invest heavily in equipment, consumables, and services. Additionally, the high adoption rate of advanced technologies, such as automated sterilization systems and air purification units, further boosts market growth. Canada also plays a significant role, focusing on enhancing infection prevention through public health campaigns and healthcare modernization.

Europe is another dominant region in the HAI Control market, driven by a strong healthcare system and a focus on patient safety. The European Union has introduced regulations aimed at improving infection prevention and reducing the incidence of hospital-acquired infections, fostering market growth. Countries like Germany, the UK, and France have well-established healthcare infrastructures and are increasingly adopting advanced infection control technologies, such as UV sterilization and antimicrobial surface coatings. The region's emphasis on maintaining high healthcare standards, combined with rising awareness and demand for effective infection control solutions, positions Europe as a key player in the market. Additionally, the European market benefits from strong collaborations between healthcare providers and infection control solution suppliers, ensuring widespread adoption of best practices.

Hospital Acquired Infection Control Market- Competitive Landscape:

The competitive dynamics of the Hospital Acquired Infection (HAI) Control market are shaped by a mix of established players and new entrants focusing on advanced technologies. Major companies like 3M, Belimed Inc., Getinge, and STERIS dominate the market with a comprehensive range of infection control solutions, including sterilization systems, disinfectants, and personal protective equipment (PPE). These companies are known for their emphasis on product quality, regulatory compliance, and robust R&D efforts to enhance product features. They also make significant investments in digital health solutions to improve infection surveillance and tracking. Additionally, new entrants and innovators, such as W&H and Midmark Corporation, are introducing advanced sterilization equipment and automation systems to improve safety and efficiency. For instance, Sterigenics, a key player in the market, focuses on gamma sterilization technology and expanding its sterilization capabilities globally. This competitive environment fosters innovation and drives improvements in infection control protocols, benefiting healthcare providers and patient outcomes.s

Recent Developments:

In September 2023, 3M launched the Clean-Coat Surface Protectant, a coating designed to eliminate up to 99.9% of bacteria and viruses on high-touch surfaces in hospitals. This innovation aims to reduce the risk of cross-contamination in healthcare environments.

In October 2023, Getinge expanded its sterilization capabilities by acquiring Healthmark Industries Co., Inc., strengthening its position in the U.S. infection control market and enhancing its offerings for instrument sterilization and compliance.

In March 2024, W&H introduced the eLog system, a digital logbook that automatically records and saves sterilization cycles and routine tests. This system enhances workflow efficiency while ensuring compliance with sterilization documentation requirements.

In July 2024, Midmark Corporation unveiled its next-generation M11 and M9 steam sterilizers, featuring enhanced durability and integrated capabilities to streamline instrument processing and improve compliance documentation efficiency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

3M
Belimed Inc.
O&M Halyards
Getinge
ASP (Advanced Sterilization Products Services, Inc.)
Sterigenics U.S., LLC - A Sotera Health Company
MMM Group
Midmark Corporation
STERIS
W&H
Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Equipment
Sterilization Equipment
Heat Sterilization Equipment
Low Temperature Sterilization
Radiation Sterilization
Disinfection Equipment
Washer Disinfector
Flusher Disinfector
Endoscopic Reprocessor Systems
Services
Consumables
Disinfectants
Sterilization Consumables

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

Hospitals and Intensive Care Units (ICUs)
Ambulatory Surgical and Diagnostic Centres
Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Hospital Acquired Infection Control Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hospital Acquired Infection Control Market Snippet by Type
- 2.1.2. Hospital Acquired Infection Control Market Snippet by End-Use
- 2.1.3. Hospital Acquired Infection Control Market Snippet by Country
- 2.1.4. Hospital Acquired Infection Control Market Snippet by Region
2.2. Competitive Insights

3. Hospital Acquired Infection Control Key Market Trends

3.1. Hospital Acquired Infection Control Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hospital Acquired Infection Control Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hospital Acquired Infection Control Market Opportunities
3.4. Hospital Acquired Infection Control Market Future Trends

4. Hospital Acquired Infection Control Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hospital Acquired Infection Control Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hospital Acquired Infection Control Market Landscape

6.1. Hospital Acquired Infection Control Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hospital Acquired Infection Control Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Equipment
  - 7.1.2.1. Sterilization Equipment
  - 7.1.2.1.1. Heat Sterilization Equipment
  - 7.1.2.1.2. Low Temperature Sterilization
  - 7.1.2.1.3. Radiation Sterilization
  - 7.1.2.2. Disinfection Equipment
  - 7.1.2.2.1. Washer Disinfector
  - 7.1.2.2.2. Flusher Disinfector
  - 7.1.2.2.3. Endoscopic Reprocessor Systems
- 7.1.3. Services
- 7.1.4. Consumables
  - 7.1.4.1. Disinfectants
  - 7.1.4.2. Sterilization Consumables

8. Hospital Acquired Infection Control Market - By End-Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 8.1.2. Hospitals and Intensive Care Units (ICUs)
- 8.1.3. Ambulatory Surgical and Diagnostic Centres
- 8.1.4. Others

9. Hospital Acquired Infection Control Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Hospital Acquired Infection Control Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Hospital Acquired Infection Control Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Hospital Acquired Infection Control Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Hospital Acquired Infection Control Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Hospital Acquired Infection Control Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hospital Acquired Infection Control Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. 3M
- 10.2.2. Belimed Inc.
- 10.2.3. O&M Halyards
- 10.2.4. Getinge
- 10.2.5. ASP (Advanced Sterilization Products Services, Inc.)
- 10.2.6. Sterigenics U.S., LLC - A Sotera Health Company
- 10.2.7. MMM Group
- 10.2.8. Midmark Corporation
- 10.2.9. STERIS
- 10.2.10. W&H
- 10.2.11. Others